GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q1 2023

SEC EDGAR SourceSEC Filings

Top Holdings54 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

1.2M$491M10.8%
Increased

THE CIGNA GROUP

1.9M$472.9M10.4%$209.52+15.30%
18 qtrssince 2018-Q4
Increased
61

TENET HEALTHCARE CORP

7.3M$431.8M9.5%$27.66+108.26%
18 qtrssince 2018-Q4
Decreased
0

FISERV INC

2.2M$243.1M5.3%$103.02+9.69%
15 qtrssince 2019-Q3
Decreased
0

GLOBAL PAYMENTS INC

2.2M$236.2M5.2%$150.66-33.36%
10 qtrssince 2020-Q4
Decreased
0

DXC TECHNOLOGY CO

9M$228.9M5.0%$38.82-35.44%
18 qtrssince 2018-Q4
Decreased
0

MCKESSON CORP

639,937$227.8M5.0%$144.46+144.44%
18 qtrssince 2018-Q4
Decreased
0

VALVOLINE INC

3.8M$132.9M2.9%$29.39+18.14%
5 qtrssince 2022-Q1
Increased
56

US FOODS HOLDING CORP

3.6M$132.7M2.9%$36.59-0.30%
6 qtrssince 2021-Q4
Decreased
0

ALIGHT INC

14.1M$130.3M2.9%$8.11+5.03%
3 qtrssince 2022-Q3
Increased
79

HCA HOLDINGS INC

452,227$119.2M2.6%$154.36+64.43%
18 qtrssince 2018-Q4
Increased
53

UNIVERSAL HEALTH SERVICES-B

862,103$109.6M2.4%$138.92-11.16%
2 qtrssince 2022-Q4
Decreased
0

CLARIVATE PLC

11.6M$109.2M2.4%$9.81-5.51%
4 qtrssince 2022-Q2
Increased
59

APTIV PLC

932,941$104.7M2.3%$109.15+0.69%
10 qtrssince 2020-Q4
Increased
52

CORTEVA INC

1.6M$98.9M2.2%$47.92+21.26%
14 qtrssince 2019-Q4
Increased
83

FMC CORP

802,666$98M2.2%$83.08+29.97%
18 qtrssince 2018-Q4
Increased
57

MYRIAD GENETICS INC

4.2M$97.5M2.1%$18.89+19.25%
15 qtrssince 2019-Q3
Increased
67

UBER TECHNOLOGIES INC

3M$94.4M2.1%$40.30-22.60%
8 qtrssince 2021-Q2
Decreased
0

DUPONT DE NEMOURS INC

1.2M$87.3M1.9%$80.47+5.05%
10 qtrssince 2020-Q4
Increased
50

ACTIVISION BLIZZARD INC

838,662$71.8M1.6%
6 qtrssince 2021-Q4
Decreased
0
$4.6B
AUM
54
Positions
Q1 2023
Filing
Rating · 4.0
Quarterly Portfolio Change
-15%Q4'21$4.7B+5%Q1'22$4.9B-19%Q2'22$4B+0%Q3'22$4B+13%Q4'22$4.5B+1%Q1'23$4.6B
Activity profile
$ moved · Q1'23
New16%Increased44%Decreased13%Exited27%
Composition
Equity vs derivatives
Equity89%Puts11%Calls0%
Holding period
Avg 2.4 years
<1Q11%1-4Q9%1-2Y22%2Y+57%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $4.6B across 54 positions as of Q1 2023. Top holdings: SPY (10.8%), CI (10.4%), THC (9.5%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q1 2023 Summary

Active quarter - 15 new positions, 13 exits, 20 increased. Top move: CTVA (INCREASED, conviction 83). Portfolio: $4.6B across 54 positions.

Top holdings by portfolio weight

Total AUM$4B
CI10.38%
THC9.47%
FISV5.33%
GPN5.18%
DXC5.02%
MCK5.00%
VVV2.92%
USFD2.91%
ALIT2.86%
HCA2.62%
Other2.40%

Portfolio allocation by GICS sector

Sectors9
Healthcare41.73%
Technology15.44%
Industrials10.89%
Consumer Cyclical8.97%
Basic Materials8.47%
Unknown7.94%
Consumer Defensive5.04%
Communication Services1.26%
Financial Services0.27%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Industrials
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record72
Conviction49
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PAYMENTS INC
Q2 2025 Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON.COM INC
Q3 2025 Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used